FDA Grants Accelerated Approval to a New Breast Cancer Treatment

View source ↗

Summary

FDA grants accelerated approval to a new treatment for adult patients with advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting new treatments to patients who need them.